lurbinectedin, JEMPERLI 500 mg concentrate for solution for infusion
Phase 2 small_molecule active
Quick answer
lurbinectedin, JEMPERLI 500 mg concentrate for solution for infusion for Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active